No Advantage of vasopressin for Cardiac Arrest
Survival to hospital discharge was similar in patients treated with vasopressin or epinephrine.
Current advanced cardiac life support (ACLS) guidelines recommend giving epinephrine every 3 to 5 minutes for patients in cardiac arrest. Vasopressin may replace the first or second epinephrine dose. Several studies have found no survival benefit for vasopressin (JW Emerg Med Jul 2 2008), but some investigators speculate that it might be advantageous in patients with prolonged arrest.
Investigators in Singapore randomized 727 patients with nontraumatic cardiac arrest to receive epinephrine (1 mg) or vasopressin (40 IU) as the first medication while ACLS proceeded in standard fashion. Arrest occurred outside the hospital in 585 patients (80%), and their mean time to emergency department arrival was 38 minutes. There were no significant differences between the vasopressin and epinephrine groups in rates of return of spontaneous circulation (32% and 30%), survival to hospital admission (22% and 17%), or survival to hospital discharge (2.9% and 2.3%).
Related Link: //www.nurftech.com/detail/129407.html
copyright©金宝搏网站登录技巧 版权所有,未经许可不得复制、转载或镜像
京ICP证120392号 京公网安备110105007198 京ICP备10215607号-1 (京)网药械信息备字(2022)第00160号